State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China; Department of Cardiology, Shenzhen People's Hospital, Shenzhen, China.
State Key Laboratory of Organ Failure Research, Department of Cardiology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Ann Palliat Med. 2021 Dec;10(12):12061-12071. doi: 10.21037/apm-21-2297.
Chronic heart failure (CHF) is a major public health burden and is associated with high morbidity, mortality, and cost. Recent studies demonstrated iron metabolism and myocardial energy metabolism were altered in CHF patients. In this study, we aimed to analyze the effects and correlations of iron metabolism on myocardial energy metabolism in CHF.
One hundred and thirty patients with CHF [age: 66.2±11.5 years, males: 58.5% and New York Heart Association (NYHA) class (II/III/IV): 67/43/20] were included. Serum concentrations of ferritin, transferrin saturation (Tsat), and soluble transferrin receptor (sTfR) were quantified as the indexes of iron metabolism, and echocardiography was used to assess myocardial energy expenditure (MEE) levels. Iron deficiency (ID) was defined as ferritin <100 or 100-300 µg/L with Tsat <20%.
Patients with CHF were divided into two groups based on iron status. The prevalence of ID in CHF was 36.9%, and increased with the severity of CHF, reaching 80.0% in those with NYHA class IV (NYHA class II/III/IV: 17.9% vs. 46.5% vs. 80.0%, P=0.000). The demographic characteristics [age, sex, body mass index (BMI), blood pressure, and heart rate] and hemoglobin (HGB) concentrations in two groups were similar (all P>0.05). MEE was significantly higher in the ID group (92.7±23.0 vs. 65.6±20.8 cal/min, P=0.000), while NYHA classes II and III was significantly higher in the ID group (71.6±16.4 vs. 60.3±14.8 cal/min, P=0.022; 88.9±10.4 vs. 69.1±20.1 cal/min, P=0.000). In univariable linear regression models, the presence of ID, higher NYHA class, increased N-terminal pro-B-type natriuretic peptide (NT-proBNP), sTfR, left ventricular internal diastolic diameter (LVIDd), as well as reduced ferritin, Tsat levels, and lower left ventricular ejection fraction (LVEF) were associated with elevated MEE levels (all P<0.05). In multivariable regression models, the presence of ID, reduced Tsat. and increased sTfR remained independent predictors of elevated MEE levels after adjustment for all variables that showed a significant association with MEE (all P<0.05).
The prevalence of ID is high in CHF and is associated with the severity of cardiac dysfunction. The presence of ID as well as reduced Tsat and increased sTfR concentrations are associated with elevated MEE levels in CHF.
慢性心力衰竭(CHF)是一个主要的公共卫生负担,与高发病率、死亡率和成本有关。最近的研究表明,CHF 患者的铁代谢和心肌能量代谢发生了改变。在这项研究中,我们旨在分析铁代谢对 CHF 患者心肌能量代谢的影响及其相关性。
纳入 130 例 CHF 患者[年龄:66.2±11.5 岁,男性:58.5%,纽约心脏协会(NYHA)分级(II/III/IV):67/43/20]。血清铁蛋白、转铁蛋白饱和度(Tsat)和可溶性转铁蛋白受体(sTfR)浓度被量化为铁代谢指标,超声心动图用于评估心肌能量消耗(MEE)水平。铁缺乏(ID)定义为铁蛋白<100 或 100-300μg/L 且 Tsat<20%。
根据铁状态将 CHF 患者分为两组。CHF 患者 ID 的患病率为 36.9%,并随着 CHF 严重程度的增加而增加,在 NYHA 分级 IV 的患者中达到 80.0%(NYHA 分级 II/III/IV:17.9% vs. 46.5% vs. 80.0%,P=0.000)。两组患者的人口统计学特征[年龄、性别、体重指数(BMI)、血压和心率]和血红蛋白(HGB)浓度相似(均 P>0.05)。ID 组的 MEE 显著较高(92.7±23.0 vs. 65.6±20.8 cal/min,P=0.000),而 ID 组的 NYHA 分级 II 和 III 显著较高(71.6±16.4 vs. 60.3±14.8 cal/min,P=0.022;88.9±10.4 vs. 69.1±20.1 cal/min,P=0.000)。在单变量线性回归模型中,存在 ID、更高的 NYHA 分级、升高的 N 末端 B 型利钠肽前体(NT-proBNP)、sTfR、左心室内部舒张直径(LVIDd),以及降低的铁蛋白、Tsat 水平和降低的左心室射血分数(LVEF)与升高的 MEE 水平相关(均 P<0.05)。在多变量回归模型中,存在 ID、降低的 Tsat 和升高的 sTfR 在调整与 MEE 有显著相关性的所有变量后,仍然是升高的 MEE 水平的独立预测因子(均 P<0.05)。
CHF 患者中 ID 的患病率较高,与心功能障碍的严重程度相关。存在 ID 以及降低的 Tsat 和升高的 sTfR 浓度与 CHF 患者的升高的 MEE 水平相关。